Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
37 /100
MEDIUM RISK
Score updated Oct 13, 2026

NEPH — Nephros, Inc. Dilution Risk Tracker

Track NEPH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NEPH — Get alerts when the score changes →

As of October 13, 2026, Nephros, Inc. (NEPH) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. Nephros, Inc. has a market capitalization of $38.77M, 10.86M shares outstanding, 28 institutional holders tracked. Stored dilution-related fields include 7.10M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
27
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 30%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 65% of shares outstanding
• Warrant risk score very high (90/100)
🔔 Track NEPH — Get forecast alerts →

Market Data

Market Cap$38.77M
Shares Outstanding10.86M
Float8.83M
Cash$4.70M
Debt$571.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore37/100DilutionWatch score record
Shares Outstanding10.86MVerified float table or market cache
Public Float8.83MVerified float table or market cache
Market Cap$38.77MMarket data cache
Cash Runway32.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants7.10MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: FORM 4 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 6.0% shares (2026Q1 vs prior)
28 institutional holders · 5.62M shares
#1 WEXFORD CAPITAL LP 3.60M shares
#2 Topline Capital Management, LLC 582.0K shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 397.3K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest25.3K
Days to Cover1.4
% of Float0.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2024-03-15
Form 4 INSIDER TRANSACTION 2026-08-12
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NEPH Dilution Snapshot

Nephros, Inc. (NEPH) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NEPH's DilutionScore is currently 37/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 27/100 (Medium risk).

Period Score Risk Level Duration
Oct 07 – Oct 13, 202637/100MEDIUM7 days
Aug 14 – Oct 06, 202627/100MEDIUM53 days
Jul 16 – Aug 13, 202623/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NEPH shares outstanding have increased 2.2% from 10.63M (Mar 2026) to 10.86M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202610.86M8.83M▲ 0.37%
May 16, 202610.86M8.79M▲ 0.47%
May 10, 202610.86M8.75M▲ 1.99%
May 06, 202610.86M8.58M▲ 0.57%
May 04, 202610.64M8.53M▼ 9.66%
Mar 28, 202610.64M9.45M▼ 1.96%
Mar 21, 202610.64M9.63M▼ 0.04%
Mar 17, 202610.63M9.64M▲ 0.02%
Mar 14, 202610.63M9.64M▲ 0.17%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NEPH Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NEPH files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NEPH — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NEPH
NEPH FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.